Northwest Biotherapeutics Inc (QB) (NWBO)
USOTC
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 623k | 336k | 412k | 2.41M | 1.29M | 1.01M | 1.68M | 1.93M |
Operating Income | -79.27M | -54.68M | -44.76M | -27.46M | -86.61M | -52.7M | -67.18M | -55.51M |
Pre Tax Income | -80.21M | -73.14M | -35.88M | -20.3M | -529.82M | 179.13M | -105.03M | -62.6M |
Net Income | -85.86M | -74.41M | -53.64M | -20.3M | -529.82M | 179.13M | -105.03M | -64.37M |
Preferred Dividends | 0 | -1.27M | -17.77M | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.547 | -0.226 | -0.103 | -0.033 | -0.639 | 0.189 | -0.098 | -0.056 |
EBIT | -86.1M | -67.25M | -41.48M | -29.4M | -88.19M | -53.35M | -67.15M | -55.59M |
EBITDA | -79.08M | -54.24M | -43.47M | -27.44M | -86.52M | -52.38M | -65.93M | -53.98M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.